News & Updates

Low baroreflex sensitivity tied to higher BP, BP variability

20 Jan 2023

Lower cardiovagal baroreflex sensitivity (BRS) appears to contribute to a higher mean blood pressure (BP) from the short- to midterm range and to BP variability, albeit not consistently, results of the Maastricht study have shown.

Low baroreflex sensitivity tied to higher BP, BP variability

20 Jan 2023

Death after out-of-hospital cardiac arrest highest within first 3 years

19 Jan 2023 by

The mortality rate following an incidence of out-of-hospital cardiac arrest (OHCA) is highest in the first 3 years post-event, gradually reducing over time, according to a study from Singapore.

Death after out-of-hospital cardiac arrest highest within first 3 years

19 Jan 2023

High uric acid levels linked to atrial fibrillation risk

18 Jan 2023

Elevated uric acid concentration appears to contribute to an increased risk of atrial fibrillation (AF) regardless of the presence of cardiovascular disease and cardiovascular risk factors, according to a study.

High uric acid levels linked to atrial fibrillation risk

18 Jan 2023

CVD, mood disorders up risk of dementia in RA patients

17 Jan 2023 by

Among patients with rheumatoid arthritis (RA), those with clinically active RA, cardiovascular or cerebrovascular disease (CVD), hypertension, depression, and anxiety are at greater risk of dementia, reveals a study. Among CVD events, ischaemic stroke and heart failure are significantly associated with an increased dementia risk.

CVD, mood disorders up risk of dementia in RA patients

17 Jan 2023

Septal reduction reduces HF readmission, improves survival in oHCM patients

17 Jan 2023

Septal reduction therapies (SRT) lower the readmission rates for heart failure (HF) in Medicare patients with obstructive hypertrophic cardiomyopathy (oHCM), a study has shown.

Septal reduction reduces HF readmission, improves survival in oHCM patients

17 Jan 2023

Regional antibiotic delivery a viable option for patients with device implant infections

16 Jan 2023

Delivery of continuous, in situ–targeted, ultrahigh concentration of antibiotics (CITA) is a safe and effective therapy for patients with pocket infection who are neither suited nor willing to undergo extraction of implanted cardiovascular electronic device, reports a study.

Regional antibiotic delivery a viable option for patients with device implant infections

16 Jan 2023

Higher LDL triglycerides up atherosclerotic CVD risk

16 Jan 2023

Elevated low-density lipoprotein (LDL) triglycerides appear to increase the risk of atherosclerotic cardiovascular disease (ASCVD) and of each ASCVD component, according to a study.

Higher LDL triglycerides up atherosclerotic CVD risk

16 Jan 2023

DOACs on par with VKAs in octogenarians with VTE

14 Jan 2023

Direct oral anticoagulants (DOACs) are as effective and safe as vitamin K antagonists (VKAs) among octogenarians with venous thromboembolism (VTE), a study has shown.

DOACs on par with VKAs in octogenarians with VTE

14 Jan 2023

Exercise intensity differently affects coronary atherosclerosis progression

10 Jan 2023

Vigorous intensity exercise helps slow the progression of coronary atherosclerosis, whereas very vigorous intensity exercise seems to be associated with greater progression, according to a study that involved male athletes.

Exercise intensity differently affects coronary atherosclerosis progression

10 Jan 2023

Emerging organ protective therapies in T2DM

10 Jan 2023 by

The goals of diabetes care are to prevent complications and optimize quality of life. Current developments in diabetes management have shifted focus from just glycemic control to the inclusion of organ protection. In the Boehringer Ingelheim-sponsored webinar entitled “Deep dive in EMPA-KIDNEY” held last December 9, 2022, Dr Nestor Eric Laplano, Consultant, Skyline Hospital and Medical Center and Grace General Hospital, SJDM Bulacan; and Dr David Cherney, Active Consultant, University Health Network and Mount Sinai Hospital Toronto Canada, revisited treatment strategies and discussed the EMPA-KIDNEY trial and its implications in organ protective therapies for type 2 diabetes.

[ Dr David Cherney ]
Dr David Cherney
Speaker

[ Dr Nestor Eric Laplano ]
Dr Nestor Eric Laplano
Moderator

Emerging organ protective therapies in T2DM

10 Jan 2023

News & Updates

Filter by Specialty:

Specialty:

Low baroreflex sensitivity tied to higher BP, BP variability

Low baroreflex sensitivity tied to higher BP, BP variability

Death after out-of-hospital cardiac arrest highest within first 3 years

Death after out-of-hospital cardiac arrest highest within first 3 years

High uric acid levels linked to atrial fibrillation risk

High uric acid levels linked to atrial fibrillation risk

CVD, mood disorders up risk of dementia in RA patients

CVD, mood disorders up risk of dementia in RA patients

Septal reduction reduces HF readmission, improves survival in oHCM patients

Septal reduction reduces HF readmission, improves survival in oHCM patients

Regional antibiotic delivery a viable option for patients with device implant infections

Regional antibiotic delivery a viable option for patients with device implant infections

Higher LDL triglycerides up atherosclerotic CVD risk

Higher LDL triglycerides up atherosclerotic CVD risk

DOACs on par with VKAs in octogenarians with VTE

DOACs on par with VKAs in octogenarians with VTE

Exercise intensity differently affects coronary atherosclerosis progression

Exercise intensity differently affects coronary atherosclerosis progression

Emerging organ protective therapies in T2DM

Emerging organ protective therapies in T2DM